drugset / Trial / NCT02382094

Clinical Trial to Study Quality of Life in Prostate Cancer Patients by Randomizing Anti-androgen Versus Total Androgen Blockage Prior to Curative Intended Radiation Therapy

NCT02382094

Phase 3 Completed 110 enrolled Karolinska University Hospital
RandomizedParallel-groupOpen-labelHealth-services research

Summary

Phase III clinical trial to study quality of life in prostate cancer patients by randomizing anti-androgen versus total androgen blockage prior to curative intended radiation therapy.

Timeline

Start
2005-06
Primary completion
2009-04
Completion
2012-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Bicalutamide Other / unclassified 50 mg Oral
Subject Bicalutamide Other / unclassified 150 mg Oral

Indications